Rasonque offers a new targeted treatment option for metastatic pancreatic cancer. Dr. Kristin Higgins explains the approval, trial results and side effects.
Dr. Kristin Higgins
Advertisement
Articles by Dr. Kristin Higgins
Advertisement
Latest Updated Articles
Advertisement
Advertisement
Trending on CURE
1
Dolly Parton, 80, Dies Following a Brief Battle with Cancer
2
FDA Approves Rasonque, First-in-Class Targeted Therapy for Metastatic Pancreatic Cancer
3
Life After Cancer: Finding Success and Purpose as a Testicular Cancer Survivor
4
Oncologist Explains What the Rasonque Approval Means for Patients With Metastatic Pancreatic Cancer
5